
Hepatitis C Virus–Escape Studies for Human Monoclonal Antibody AR4A …
Jan 1, 2019 · Our findings indicate that AR4A targets a low-variation epitope with a high barrier to resistance, which in conjunction with high AR4A cross-genotype conservation makes the epitope a prime candidate for inclusion in HCV vaccine candidates.
Structure of the hepatitis C virus E1E2 glycoprotein complex
Here, we present the cryo–electron microscopy structure of the membrane-extracted full-length E1E2 heterodimer in complex with three broadly neutralizing antibodies—AR4A, AT1209, and IGH505—at ~3.5-angstrom resolution.
Human broadly neutralizing antibodies to the envelope …
Apr 4, 2012 · In particular, the mAb AR4A, recognizing a discontinuous epitope outside the CD81bs on the E1E2 complex, has an exceptionally broad neutralizing activity toward diverse HCV genotypes and protects against heterologous HCV challenge in a small animal model.
Structure of engineered hepatitis C virus E1E2 ectodomain in …
Jul 5, 2023 · Here, we present a cryo-EM structure of an engineered, secreted E1E2 ectodomain of genotype 1b in complex with neutralizing antibodies AR4A, HEPC74, and IGH520.
Cross-genotype AR3-specific neutralizing antibodies confer long …
Jul 1, 2019 · AR3-specific antibodies neutralized HCV pseudoparticles and cell culture viruses. A large number of clearers develop antibodies targeting antigenic region 4 (AR4). AR4-specific antibody AT1618 also neutralized neutralization-resistant variants.
Identification of novel neutralizing determinants for protection ...
Feb 17, 2023 · We evaluated passaged viruses for fitness in viral kinetic assays and for exposure of conserved neutralizing epitopes using mAb targeting AR2, AR3, AR4, and AR5 in neutralization assays.
Mechanisms of HCV resistance to broadly neutralizing antibodies
Jul 28, 2021 · E1E2 variants with resistance to both HC33.4 (an AS412 bNAb) and AR4A (an E1E2 bNAb) were identified using a large panel of HCVpp generated using natural E1E2 isolates.
Hepatitis C Virus-Escape Studies for Human Monoclonal Antibody AR4A …
Jan 1, 2019 · Global control of hepatitis C virus (HCV) depends on development of a prophylactic vaccine. We studied escape for cross-genotype-reactive neutralizing antibody AR4A, providing valuable information for HCV vaccine design. We cultured HCV core-NS2 recombinants H77 (genotype 1a)/JFH1 or the highly anti …
The exporter needs to apply on a form known as AR4 or AR4A to the Central Excise Range Superintendent for obtaining excise clearance. Form A is filed when goods are to be cleared after examination by the excise
Here, we present the cryo–electron microscopy structure of the membrane-extracted full-length E1E2 heterodimer in complex with three broadly neutralizing antibodies — AR4A, AT1209, and IGH505 at ~3.5-angstrom resolution.
- Some results have been removed